Improved Translational Relevance of In Vitro Fibrosis Models by Integrating IOX2-Mediated Hypoxia-Mimicking Pathways

Area of Science:

• Biomedical research
• Cell biology
• Translational medicine

Background:

• Preclinical models of liver fibrosis incompletely replicate human disease.
• Traditional hepatic stellate cell (HSC) models lack crucial hypoxia-induced pathways.

Purpose of the Study:

• To investigate if a hypoxia-mimicking compound (IOX2) can improve the accuracy of HSC models for liver fibrosis.
• To assess the functional fibrotic phenotype in vitro.

Main Methods:

• Human primary HSCs were stimulated with transforming growth factor beta 1 (TGFβ1) with or without IOX2.
• Fibrotic markers (collagen, TIMP-1, Fibronectin) and cell viability were measured.
• Next-generation sequencing (NGS) and pathway analysis (IPA) were used for mechanistic insights.

Main Results:

• TGFβ1 + IOX2 significantly elevated fibrotic marker levels.
• Hypoxia-related genes and collagen modifications increased dose-dependently.
• The IOX2-treated model showed improved representation of human fibrotic gene expression.

Conclusions:

• IOX2 administration enhances the ability of HSC models to recapitulate liver fibrosis.
• Hypoxia-mimicking compounds can improve the translational value of in vitro fibrosis models.
• This approach offers valuable insights into liver fibrosis pathogenesis and therapeutic strategies.